A review of Johnson & Johnson (JNJ), a recognized global leader and manufacturer of health care products.
Written in 2006; 3,003 words; 5 sources; MLA; $ 88.95
Paper Summary:
This paper reviews and discusses the global leader in health care products, Johnson & Johnson (JNJ). According to the paper, JNJ has over 200 subsidiaries with offices in nearly every nation of the world. The paper reports that Johnson & Johnson has gone through a variety of structural and organizational structures in the last twenty years and today is centered on a market segment-based approach which comprises their consumer, medical devices & diagnostics and pharmaceuticals businesses.
Outline:
Company Description
Business Segments are aligned to Target Markets
Pharmaceutical Segment
Medical Devices & Diagnostics
Consumer
Product Strategy
Pricing Strategies
Distribution Strategy
Promotions and Marketing Communications
Conclusion
From the Paper:
"JNJ's move into markets that require more sophistication in drug development and production is also exemplified by their move into the market for medications to treat Schizophrenia, an area of their business that made up 18% of total 2006 pharmaceutical revenues. The anemia market is another source of challenge for the company as price erosion has been necessary to stem market share losses. We assume revenue erosion in the mid-single digits over the next 3 years with continued competition from Amgen and some modest negative effects from Roche's Cera, expected to launch in May 2007. The anemia franchise (Procrit/Eprex) made up 14% of JNJ's pharmaceutical sales in 2006.
The MD&D division has enjoyed industry leadership, particularly at the company's Cordis business. This previously fast-growing business made up 20% of JNJ's MD&D sales in 2006 and a significant proportion of its profit. Noteworthy competition from Boston Scientific, Abbott, and Medtronic is likely to erode market share beginning in 2007, driving Cordis sales declines in the range of 4% to 19% in 2007-10. The Conor acquisition is expected to be successful.The Consumer division should benefit from the recent acquisition of Pfizer's consumer line."
We have thousands of high-quality term papers, research papers, essays, book reports and dissertations on every topic. At AcaDemon, you can download those term papers to help you write yours! You can be sure that the term paper, essay, book report or research paper you download are top-quality, competitively priced and high-level work.
This Free Term Paper Abstract is a part of our Term Paper Library.Here you can purchase research papers, examples of essays, academic dissertations, articles, notes, analytical papers, book reports, stories and poems. We have thousands of persuasive, point-of-view, narrative, critical, compare and contrast and other types of essays in our Library. You can also find here Term papers on "Johnson & Johnson's Marketing Mix", Essays on "Johnson & Johnson's Marketing Mix", Research papers on "Johnson & Johnson's Marketing Mix", Student papers on "Johnson & Johnson's Marketing Mix", Book reports on "Johnson & Johnson's Marketing Mix", Dissertation on "Johnson & Johnson's Marketing Mix", Thesis on "Johnson & Johnson's Marketing Mix", Summary of paper on "Johnson & Johnson's Marketing Mix", Articles written on "Johnson & Johnson's Marketing Mix".
Look for more research papers, essays and book reports on